Tilray Brands (TLRY) Revenue Growth (1y) (2018 - 2026)
Tilray Brands (TLRY) Revenue Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -0.81% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -0.24% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.07% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -1.92% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 4.88% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 39.49% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 10.23% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Tilray Brands | 523.93 Mn | 289.30 Mn | 90.52 Mn | 25.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 25.47% |
| Feb 28, 2026 | 11.28% |
| Nov 30, 2025 | 3.11% |
| Aug 31, 2025 | 4.73% |
| May 31, 2025 | -2.33% |
| Feb 28, 2025 | -1.36% |
| Nov 30, 2024 | 8.87% |
| Aug 31, 2024 | 13.05% |
| May 31, 2024 | 24.81% |
| Feb 29, 2024 | 29.36% |
| Nov 30, 2023 | 34.44% |
| Aug 31, 2023 | 15.49% |
| May 31, 2023 | 20.13% |
| Feb 28, 2023 | -4.14% |
| Nov 30, 2022 | -7.10% |
| Aug 31, 2022 | -8.82% |
| May 31, 2022 | 7.80% |
| Feb 28, 2022 | 22.58% |
| Nov 30, 2021 | 19.85% |
| Aug 31, 2021 | 43.01% |